Frankhouser D, Dietze E, Mahabal A, Seewaldt V
Front Radiol. 2023; 1:735567.
PMID: 37492179
PMC: 10364989.
DOI: 10.3389/fradi.2021.735567.
Chhetri A, Li X, Rispoli J
Front Med (Lausanne). 2020; 7:175.
PMID: 32478083
PMC: 7235971.
DOI: 10.3389/fmed.2020.00175.
Huang J, Schafer S, Aben G, Hoisington L
J Appl Clin Med Phys. 2015; 16(5):389–395.
PMID: 26699291
PMC: 5690164.
DOI: 10.1120/jacmp.v16i5.5187.
Jung H, Han B, Ko E, Shin J
J Breast Cancer. 2014; 17(3):270-8.
PMID: 25320626
PMC: 4197358.
DOI: 10.4048/jbc.2014.17.3.270.
Cai H, Peng Y, Ou C, Chen M, Li L
PLoS One. 2014; 9(1):e87387.
PMID: 24498092
PMC: 3909149.
DOI: 10.1371/journal.pone.0087387.
Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound.
Luciani M, Pediconi F, Telesca M, Vasselli F, Casali V, Miglio E
Radiol Med. 2011; 116(6):886-904.
PMID: 21293943
DOI: 10.1007/s11547-011-0630-8.
Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI.
Caproni N, Marchisio F, Pecchi A, Canossi B, Battista R, DAlimonte P
Eur Radiol. 2009; 20(6):1384-95.
PMID: 20033178
DOI: 10.1007/s00330-009-1690-1.
Adjunctive diagnostic value of MRI in the breast radial scar.
Perfetto F, Fiorentino F, Urbano F, Silecchia R
Radiol Med. 2009; 114(5):757-70.
PMID: 19484584
DOI: 10.1007/s11547-009-0405-7.
Correlation between high resolution dynamic MR features and prognostic factors in breast cancer.
Lee S, Cho N, Kim S, Cha J, Cho K, Ko E
Korean J Radiol. 2008; 9(1):10-8.
PMID: 18253071
PMC: 2627175.
DOI: 10.3348/kjr.2008.9.1.10.
Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.
Fan X, Medved M, Karczmar G, Yang C, Foxley S, Arkani S
Magn Reson Imaging. 2007; 25(5):593-603.
PMID: 17540270
PMC: 2925253.
DOI: 10.1016/j.mri.2006.10.011.
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
Hauth E, Jaeger H, Maderwald S, Stockamp C, Muhler A, Kimmig R
Eur Radiol. 2006; 16(12):2834-41.
PMID: 16896702
DOI: 10.1007/s00330-006-0348-5.
Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.
Oshida K, Nagashima T, Ueda T, Yagata H, Tanabe N, Nakano S
Eur Radiol. 2005; 15(7):1353-60.
PMID: 15789211
DOI: 10.1007/s00330-005-2661-9.
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
Scheidhauer K, Walter C, Seemann M
Eur J Nucl Med Mol Imaging. 2004; 31 Suppl 1:S70-9.
PMID: 15133634
DOI: 10.1007/s00259-004-1528-7.
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
Walter C, Scheidhauer K, Scharl A, Goering U, Theissen P, Kugel H
Eur Radiol. 2003; 13(7):1651-6.
PMID: 12835981
DOI: 10.1007/s00330-002-1816-1.
